Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Brand, A. Leeuwen, JG Eernisse, JJ Rood (1978)
Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.Blood, 51 5
K. Mittal, M. Mickey, Singal Dp, P. Terasaki (1968)
SEROTYPING FOR HOMOTRANSPLANTATION XVIII. REFINEMENT OF MICRODROPLET LYMPHOCYTE CYTOTOXICITY TESTTransplantation, 6
(1973)
Selec - tion of unrelated compatible platelet donors by lymphocyte HLA - matching
U. Bucher, A. Weck, H. Spengler, L. Tschopp, H. Kummer (1973)
Platelet Transfusions: Shortened Survival of HL‐A‐Identical Platelets aud Failure of in vitro Detection of Anti‐Platelet Antibodies after Multiple TransfusionsVox Sanguinis, 25
K. Wu, J. Thompson, J. Koepke, J. Hoak, R. Flink (1976)
Heterogeneity of antibody response to human platelet transfusion.The Journal of clinical investigation, 58 2
Experimental Hematology Section, Pediatric Oncology Branch, National Cancer Institute
Head Nurse, Plasmapheresis Laboratory, National Cancer Institute
H. Lohrmann, Bull Mi, J. Decter, R. Yankee, R. Graw (1974)
Platelet transfusions from HL-A compatible unrelated donors to alloimmunized patients.Annals of internal medicine, 80 1
R. Duquesnay, D. Filip, G. Rodey, R. Aster (1977)
Transfusion therapy of refractory thrombcytopenic patients with platelets from donors selectively mismatched for cross-reactive HLA antigens.Transplantation proceedings, 9 1 Suppl 1
Capillary leukocyteag - glutination
K. Mittal, E. Ruder, D. Green (1976)
Matching of histocompatibility (HL-A) antigens for platelet transfusion.Blood, 47 1
R. Duquesnoy, D. Filip, R. Aster (1977)
Influence of HLA-A2 on the effectiveness of platelet transfusions in alloimmunized thrombocytopenic patients.Blood, 50 3
Assistant Professor,
KK Wu, JC Hoak, JA Koepke, J. Thompson (1977)
Selection of Compatible Platelet Donors: A Prospective Evaluation of Three Cross‐Matching TechniquesTransfusion, 17
K. Wu, J. Hoak, J. Thompson, J. Koepke (1975)
Use of platelet aggregometry in selection of compatible platelet donors.The New England journal of medicine, 292 3
Microleukoagglutination method
J. Gmür, A. Felten, P. Frick (1978)
Platelet support in polysensitized patients: role of HLA specificities and crossmatch testing for donor selection.Blood, 51 5
(1978)
HLAmatched platelet transfusion therapy of severe aplastic anemia
D. Filip, R. Duquesnoy, R. Aster (1976)
Predictive value of cross‐matching for transfusion of platelet concentrates to alloimmunized recipientsAmerican Journal of Hematology, 1
(1969)
A simple microcytotoxicity test
DeWeck A . Spengler H . Tschopp 1
D. Heinrich, U. Stephinger, C. Mueller-Eckhardt (1977)
Specific Interaction of HLA Antibodies (Eluates) with Washed PlateletsBritish Journal of Haematology, 35
W. Chappell (1966)
Platelet concentrates from acidified plasma: a method of preparation without the use of additives.Transfusion, 6 4
Manuscript Preparation
RH Herzig, PI Terasaki, RJ Trapani, GP Herzig, RG Graw (1977)
The Relationship between Donor‐Recipient Lymphocytotoxicity and the Transfusion Response using HLA‐Matched Platelet ConcentratesTransfusion, 17
R. Duquesnoy, D. Lorentsen, R. Aster (1975)
Platelet migration inhibition: a new method for detection of platelet antibodies.Blood, 45 6
E. Thorsby, A. Helgesen, T. Gjemdal (2008)
Repeated platelet transfusions from HL-A compatible unrelated and sibling donors.Tissue antigens, 2 5
R. Aster, R. Levin, Harvey Cooper, E. Freireich (1964)
Complement‐Fixing Platelet Iso‐Antibodies in Serum of Transfused Persons. Correlation of Antibodies with Platelet Survival in Thrombocytopenic PatientsTransfusion, 4
Capillary leukocyteagglutination. NIAID Manual of Tissue Typing Techniques
Although HLA‐matched platelet transfusions are of value in the support of some alloimmunized thrombocytopenic patients, poor posttransfusion increments can be observed following HLA‐matched platelet transfusions and conversely good posttransfusion increments may result after HLA‐mismatched platelet transfusions. We have explored the possibility that in vitro assays in addition to HLA typing might better select compatible donors for refractory recipients. Our studies suggested that a platelet migration inhibition assay is predictive of platelet transfusion responses in HLA‐compatible and incompatible donor‐recipient pairs, while lymphocyto‐toxicity is predictive of posttransfusion increments only in HLA‐incompatible donor‐recipient pairs. Granulocy‐totoxicity, microleukoagglutination, and capillary leu‐koagglutination showed no value in predicting platelet transfusion increments, either in HLA‐compatible or incompatible donor‐recipient pairs.
Transfusion – Wiley
Published: Jan 2, 1980
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.